RETINOID X RECEPTOR-GAMMA AGONISTS AND RETINOID X RECEPTOR-ALPHA ANTAGONISTS FOR TREATMENT OF CANCER
申请人:St. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
公开号:US20160324874A1
公开(公告)日:2016-11-10
The invention is directed to the use of Retinoid X Receptor-gamma (RXR-gamma) agonists and Retinoid X Receptor-alpha (RXR-alpha) antagonists in treatment of cancer.
A novel synthesis of spironolactone. An application of the hydroformylation reaction